SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Medican Enterprises, Inc. (MDCN) .
本页证实的标准:
- VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。
SharesGrow 综合评分： 45/100 其中 0/7 项标准通过。
SharesGrow 7-Criteria Score
✗
健康
25/100
Debt-to-Equity & liquidity
→ Health
估值概览 — MDCN
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.00
EV/EBITDA0.0
每股数据
EPS (TTM)$0.00
每股账面价值$0.00
每股营收$0.00
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2011 |
$0.00 |
$0.00 |
$-8.04K |
- |
| 2012 |
$-0.01 |
$0.00 |
$-18.9K |
- |
| 2013 |
$-0.14 |
$0.00 |
$-376K |
- |
| 2014 |
$-13.70 |
$0.00 |
$-56.52M |
- |
| 2019 |
$0.00 |
$624K |
$118.42K |
19% |
| 2020 |
$0.00 |
$1.1M |
$3.85M |
348.5% |
| 2021 |
$0.00 |
$4.24M |
$152.65K |
3.6% |
| 2022 |
$0.00 |
$2.61M |
$6.35M |
243.5% |
| 2023 |
$0.00 |
$0.00 |
$675.31K |
- |
| 2024 |
$0.00 |
$0.00 |
$-1.21M |
- |
